Five Decades of Filler Lawsuits, and Where They Land

A review in the Aesthetic Surgery Journal examined forty-six U.S. civil cases involving injectable fillers between 1967 and 2025. Verdicts split almost evenly overall, and autologous fat, hyaluronic acid and biostimulators were implicated in roughly equal numbers. Two findings stand out: cases arising from med-spa procedures produced a plaintiff verdict every time, against forty-seven percent in private clinics and hospitals, and cases involving products without regulatory approval did the same. Neither the injector's credentials nor the severity of the complication predicted the outcome on its own.